Showing results (411-420 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|December 13, 2002
Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screenGary K Scott, Chloe Marden, Fan Xu, et al.
Molecular Cancer Therapeutics|January 9, 2003
Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cellsPaul H Johnson, Roger P Walker, Steven W Jones, et al.
Molecular Cancer Therapeutics|January 9, 2003
Identification and characterization of the canine multidrug resistance-associated proteinLiandong Ma, Susan E Pratt, Jin Cao, et al.
Molecular Cancer Therapeutics|January 9, 2003
Endothelin-2 is a hypoxia-induced autocrine survival factor for breast tumor cellsMatthew J Grimshaw, Stuart Naylor, Frances R Balkwill
Molecular Cancer Therapeutics|January 9, 2003
Multiple comparisons model-based clustering and ternary pattern tree numerical display of gene response to treatment: procedure and application to the preclinical evaluation of chemopreventive agentsThomas R Sutter, Xiao-Rui He, Peter Dimitrov, et al.
Molecular Cancer Therapeutics|January 21, 2003
Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancerJingsong Chu, Frank L Lloyd, Ovidiu C Trifan, et al.
Molecular Cancer Therapeutics|January 21, 2003
Triptolide inhibits the growth and metastasis of solid tumorsShanmin Yang, Jinguo Chen, Zhen Guo, et al.
Molecular Cancer Therapeutics|January 21, 2003
Protein kinase C-dependent activation of the tumor necrosis factor receptor-mediated extrinsic cell death pathway underlies enhanced apoptosis in human myeloid leukemia cells exposed to bryostatin 1 and flavopiridolLeanne Cartee, Sonia C Maggio, Rebecca Smith, et al.
Molecular Cancer Therapeutics|December 20, 2002
Antiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signalingTakashi Itokawa, Hiroki Nokihara, Yasuhiko Nishioka, et al.
Molecular Cancer Therapeutics|December 20, 2002
PAGE4 is a cytoplasmic protein that is expressed in normal prostate and in prostate cancersCarlo Iavarone, Curt Wolfgang, Vasantha Kumar, et al.
Pageof 599